In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D. Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and Development Play podcast

In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&amp;D. Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and Development Play podcast

Disruptive Innovation in R&D Processes

PharmaVOICE interviews movers and shakers from the life sciences. We'll bring you interviews with executives from pharma and biotech as well as service providers to give you interesting stories from across the life sciences spectrum. It's all part of our mission to deliver a glimpse into the people who are forging the present and future of our industry.

Share Disruptive Innovation in R&D Processes

Sign up to save your podcasts

Disruptive Innovation in R&D Processes

Disruptive Innovation in R&D Processes